Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGR019 phase II maintenance study in advanced malignant pleural mesothelioma
2010-023614-31Phase 2Completed
- Sponsor
- MolMed
- Start
- Feb 2011
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pleural mesothelioma comparing NGR-hTNF maintenance with Placebo maintenance (2 arms). Primary endpoint: Progression-free survival. Started Feb 2011; status: completed.
02
Drugs
NGR-TNF
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on 2010-023614-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023614-31.